BLRX BioLineRx Ltd: Earnings per share for the last 12 months

BioLineRx Corp (BLRX) - corporate logo

Aphexda sales dynamics and the development of the oncology portfolio influence the percentage growth history of EPS YoY (ttm), where 55.40 indicates the level of this metric for BioLineRx Ltd. (BLRX). Financial stability is based on the commercialization of approved drugs. Simultaneously, software robots are being implemented to accelerate data validation. This chart helps assess the stability of earnings per share, eliminating the risks of overpaying for the asset.

BioLineRx Corp (BLRX) Earnings per share for the last twelve months: for the period 02/11/2024 - 11/12/2026

BLRX (BioLineRx Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price biolinerx.com|BLRX - Price Target Chart
- company stock capitalization data:
Market Capitalization BioLineRx Ltd|BLRX - Enterprise Value
- book capitalization indicators:
Accounting Value per Share BioLineRx|BLRX - Company Book Value|Market-to-Book Ratio biolinerx.com|BLRX - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Equity BioLineRx Ltd.|BLRX - Long-Term Debt to Equity|Current Liabilities to Capital BioLineRx Corporation|BLRX - Company Aggregate Debts|Debt to Net Assets BioLineRx Ltd|BLRX - Company Long-Term Liabilities|Short-Term Debt BioLineRx|Intermediate Coverage Ratio biolinerx.com
- earnings and market multiples details:
BLRX - Net Income|Future Net Profit BioLineRx Ltd.|BLRX - P/E Multiple|Future Price to Earnings Multiple BioLineRx Ltd|BLRX - PEG Multiple|Company Value to EBITDA BioLineRx Ltd|BLRX - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year BioLineRx|BLRX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth biolinerx.com|BLRX - Earnings per share growth in current year|Net earnings per share change forecast for next year BioLineRx Ltd.
Fundamental company valuation:BLRX biolinerx.com
Flagship merchandise of BioLineRx

This indicator measures the rolling annual growth rate of net earnings per share, smoothing out short-term fluctuations to identify the long-term profitability trend. By analyzing the rolling annual EPS YoY dynamics, an investor assesses the efficiency of BioLineRx Ltd. (BLRX) R&D expenditures in retaining leading oncologists through option programs and the capitalization of their scientific achievements.

Direct competitors

Net earnings per one share for the last twelve months incyte.com|HUTCHMED (HCM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months NUVB|DAWN (Day One Bio) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Monopar Corp (MNPR)|Earnings per share for the last twelve months Inhibrx Biosciences (INBX)|IMAB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Fennec Pharmaceuticals Inc. FENC|Heron - Earnings per share for the last twelve months|NVCT - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Coherus Biosciences|CRBP: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Cardiff Oncology CRDF|Net earnings per share for the last 12 months BYSI|Net earnings per one share for the last twelve months BioAtla Corp BCAB|Net earnings per share for the last 12 months LIXT (Lixte Biotechnology Holdings)|CTXR (citiuspharma.com) - Earnings per share for the trailing year|Cellectar Biosciences - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CANF (canfite.com)|Aprea - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KZIA (Kazia Therapeutics)|SLXN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NuCana (NCNA)|Earnings per share for the last twelve months Chimerix, Inc.|CYCC: Earnings per share for the trailing year|Net earnings per share (EPS TTM) GTHX|Net earnings per share (EPS TTM) Kronos Bio Inc (KRON)|Earnings per share for the last twelve months Kintara KTRA|ONCT (Oncternal Corp) - Earnings per one share for the last 12 months|PRTG: Net earnings per share for the last 12 months